ALBUMEDIX

Serial Number 79346631
Registration 7532407
700

Registration Progress

Application Filed
May 20, 2022
Under Examination
Approved for Publication
Jul 30, 2024
Published for Opposition
Jul 30, 2024
Registered
Oct 15, 2024

Trademark Image

ALBUMEDIX

Basic Information

Serial Number
79346631
Registration Number
7532407
Filing Date
May 20, 2022
Registration Date
October 15, 2024
Published for Opposition
July 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 15, 2024
Registration
Registered
Classes
041 042 045

Rights Holder

Sartorius Albumedix Limited

98
Address
HQ, Mabel Street
Nottingham NG2 3ED
GB

Ownership History

Albumedix Ltd

Original Applicant
99
GB

Albumedix Ltd

Owner at Publication
99
GB

Albumedix Ltd

Original Registrant
99
GB

Sartorius Albumedix Limited

New Owner After Registration #1
98
GB

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

Next Deadline
1744 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20241015)
Due Date
October 15, 2030
Grace Period Ends
April 15, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Apr 16, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 16, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 16, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 16, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 16, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 19, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 11, 2025 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Mar 20, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Mar 20, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jan 15, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 15, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 15, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 25, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 24, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 29, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jan 10, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 10, 2024 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Dec 31, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Dec 31, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Dec 31, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Nov 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 3, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 3, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 24, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
May 4, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 4, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 2, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 16, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 15, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 29, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 9, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Aug 5, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 4, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 041
Education, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and development; technical training in the field of medical, biological, biopharmaceutical, pharmaceutical and chemical analysis; information, consultancy and advisory services for the aforementioned services
Class 042
Research and development services in the field of biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, namely, providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products, and laboratory analysis in the field of medicines and pharmaceuticals; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, quality assurance in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; quality control services for others in the field of development and testing of cells; services of a scientific, chemical, and biological laboratory; development and testing of chemical, pharmaceutical, biopharmaceutical, chemical, and medical production methods; quality control services for others and authentication services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, providing quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; scientific and medical laboratory services; information, consultancy and advisory services for the aforementioned services
Class 045
Regulatory compliance auditing; regulatory compliance consultancy in the field of biotechnology, pharmaceuticals, biopharmaceuticals, and medical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services

Classification

International Classes
041 042 045